- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 53,803,111
- Total 13F shares
- 36,210,809
- Share change
- +471,493
- Total reported value
- $616,671,033
- Price per share
- $17.03
- Number of holders
- 59
- Value change
- +$8,028,494
- Number of buys
- 28
- Number of sells
- 13
Quarterly Holders Quick Answers
What is CUSIP 90240B106?
CUSIP 90240B106 identifies TYRA - Tyra Biosciences, Inc. - COMMON STOCK in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 90240B106:
Top shareholders of TYRA - Tyra Biosciences, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
13%
|
7,236,454
|
$116,289,816 | — | 31 Mar 2023 | |
| Boxer Capital, LLC |
13F
|
Company |
12%
|
6,448,359
|
$103,625,000 | — | 31 Mar 2023 | |
| Canaan Partners XI LLC |
13F
|
Company |
8.2%
|
4,409,991
|
$70,868,555 | — | 31 Mar 2023 | |
| BVF INC/IL |
13F
|
Company |
6%
|
3,239,595
|
$52,060,292 | — | 31 Mar 2023 | |
| FMR LLC |
13F
|
Company |
5.9%
|
3,147,987
|
$50,588,152 | — | 31 Mar 2023 | |
| Nextech Invest Ltd. |
13F
|
Company |
4.7%
|
2,518,582
|
$40,473,613 | — | 31 Mar 2023 | |
| TCG Crossover Management, LLC |
13F
|
Company |
3.7%
|
1,989,103
|
$31,964,885 | — | 31 Mar 2023 | |
| Alta Partners NextGen Fund II Management, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,080,296
|
$26,844,267 | — | 17 Sep 2021 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
2.6%
|
1,421,310
|
$22,840,452 | — | 31 Mar 2023 | |
| Fairmount Funds Management LLC |
13F
|
Company |
2.6%
|
1,416,998
|
$22,771,158 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.2%
|
666,885
|
$10,716,843 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.2%
|
639,324
|
$10,273,937 | — | 31 Mar 2023 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.92%
|
494,403
|
$7,945,056 | — | 31 Mar 2023 | |
| Cormorant Asset Management, LP |
3/4/5
|
Former 10% Owner |
—
class O/S missing
|
1,069,932
|
$7,039,083 | — | 17 Sep 2021 | |
| Woodline Partners LP |
13F
|
Company |
0.76%
|
410,435
|
$6,595,690 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.53%
|
286,104
|
$4,597,691 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.43%
|
232,089
|
$3,729,670 | — | 31 Mar 2023 | |
| Canaan XI L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
473,396
|
$3,114,472 | — | 17 Sep 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.36%
|
192,493
|
$3,093,000 | — | 31 Mar 2023 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.25%
|
134,173
|
$2,156,160 | — | 31 Mar 2023 | |
| Robert L. Hudkins |
3/4/5
|
Chief Technology Officer |
—
class O/S missing
|
273,576
|
$1,799,857 | — | 15 Sep 2022 | |
| Ronald Swanson V |
3/4/5
|
Chief Scientific Officer |
—
mixed-class rows
|
378,254
mixed-class rows
|
$1,797,738 | — | 06 Sep 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.2%
|
107,542
|
$1,728,200 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.19%
|
102,370
|
$1,645,086 | — | 31 Mar 2023 | |
| Esther van den Boom |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
240,542
|
$1,582,525 | — | 15 Sep 2022 | |
| Logos Global Management LP |
13F
|
Company |
0.16%
|
87,673
|
$1,408,905 | — | 31 Mar 2023 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.16%
|
84,260
|
$1,354,058 | — | 31 Mar 2023 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.09%
|
48,170
|
$774,092 | — | 31 Mar 2023 | |
| Artia Global Partners LP |
13F
|
Company |
0.08%
|
45,253
|
$727,216 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.08%
|
41,531
|
$667,403 | — | 31 Mar 2023 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.06%
|
33,760
|
$542,523 | — | 31 Mar 2023 | |
| Piyush R. Patel |
3/4/5
|
Chief Development Officer |
—
class O/S missing
|
73,794
|
$485,491 | — | 21 Feb 2023 | |
| FISHMAN JAY A LTD/MI |
13F
|
Company |
0.04%
|
22,000
|
$353,540 | — | 31 Mar 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.04%
|
21,926
|
$352,000 | — | 31 Mar 2023 | |
| Mariner, LLC |
13F
|
Company |
0.04%
|
21,529
|
$346,000 | — | 31 Mar 2023 | |
| LPL Financial LLC |
13F
|
Company |
0.04%
|
19,500
|
$313,365 | — | 31 Mar 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.03%
|
18,756
|
$301,000 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.03%
|
18,011
|
$289,436 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
15,309
|
$246,014 | — | 31 Mar 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.03%
|
13,475
|
$217,000 | — | 31 Mar 2023 | |
| Sepio Capital, LP |
13F
|
Company |
0.02%
|
10,625
|
$170,744 | — | 31 Mar 2023 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.02%
|
10,525
|
$169,137 | — | 31 Mar 2023 | |
| MVA Investors, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
22,527
|
$148,205 | — | 09 Feb 2023 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.02%
|
8,138
|
$130,778 | — | 31 Mar 2023 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.01%
|
7,702
|
$123,771 | — | 31 Mar 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
6,785
|
$109,035 | — | 31 Mar 2023 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
6,400
|
$102,848 | — | 31 Mar 2023 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.01%
|
4,930
|
$79,225 | — | 31 Mar 2023 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
4,619
|
$74,227 | — | 31 Mar 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
2,362
|
$37,957 | — | 31 Mar 2023 |
Institutional Holders of Tyra Biosciences, Inc. - COMMON STOCK (TYRA) as of Q2 2023
As of 30 Jun 2023,
Tyra Biosciences, Inc. - COMMON STOCK (TYRA) was held by
59 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,210,809 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., Boxer Capital, LLC, Canaan Partners XI LLC, FMR LLC, BVF INC/IL, Nextech Invest Ltd., TCG Crossover Management, LLC, Fairmount Funds Management LLC, Frazier Life Sciences Management, L.P., and BlackRock Inc..
This page lists
59
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
50
Q2 2023 holders
59
Holder diff
9
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.